Company Description

153 Therapeutics is focused on developing novel, best-in-class therapeutics for central nervous system (CNS) disorders such as Parkinson’s Disease, Alzheimer’s Disease and ALS, among others. Their unique approach targets nuclear receptors in the brain to regulate transcriptional activity and restore normal signaling and function.